Prostate-specific membrane antigen PET response associates with radiographic progression-free survival following stereotactic ablative radiation therapy in oligometastatic castration-sensitive prostate cancer.

Sutera, PhilipDeek, MatthewGuler, Ozan CemHurmuz, PervinReyhan, MehmetRowe, Steven P.Hrinivich, WilliamRen, LeiKiess, Ana PonceSong, Daniel Y.Oymak, EzgiPienta, Kenneth J.Pomper, MartinFeng, Felix Y.Ozyigit, GokhanTran, Phuoc T.Phillips, RyanOnal, Huseyin Cem2022-11-042022-11-0420220732-183Xhttp://hdl.handle.net/11727/8009enginfo:eu-repo/semantics/closedAccessProstate-specific membrane antigen PET response associates with radiographic progression-free survival following stereotactic ablative radiation therapy in oligometastatic castration-sensitive prostate cancer.conferenceObject4016000863680301427